In a welcome move, Linde saw its Relative Strength Rating improve from 64 to 73 on Friday.
IBD's proprietary RS Rating tracks market leadership by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
History shows that the best stocks typically have an RS Rating of above 80 as they launch their largest runs. See if Linde can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Linde is within a buy zone after breaking past a 461.90 buy point in a double bottom. The proper buying range extends to 5% above the initial entry. Once a stock moves above that range, it's best to hold off investing and wait for it to set up another buying opportunity..
In terms of top and bottom line numbers, the company has posted two quarters of accelerating earnings growth. Revenue growth has not followed the same trajectory, coming in at 0% last quarter.
Linde holds the No. 3 rank among its peers in the Chemicals-Specialty industry group. Balchem is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
